♟️ Friday 7 November 2025 Fri, 7 Nov 2025

Invex Therapeutics Ltd has been suspended from trading on the ASX due to a failure to maintain the minimum number of directors required by law. The suspension will remain until the company rectifies its governance structure and complies with listing rules.

Clean TeQ Water has raised A$6 million through a placement supported by major shareholders to fund its expanding international water and resource recovery projects while strengthening its balance sheet.

Epsilon Healthcare has posted its highest-ever quarterly receipts of $2.919 million, reflecting a robust turnaround since exiting voluntary administration in mid-2024. The company’s strategic sale and leaseback deal has also enabled significant debt reduction, setting the stage for sustained growth.

PMET Resources reports a positive feasibility study for its flagship Shaakichiuwaanaan lithium project, revealing a maiden mineral reserve and advancing environmental and exploration milestones.

TT Investments has launched an unconditional $0.31 per security takeover bid for 360 Capital Group, aiming to delist the company from the ASX. The Independent Board Committee recommends acceptance amid significant premiums and looming governance changes.

Block, Inc. reported robust Q3 2025 results, driven by strong Cash App and Square performance, and raised its full-year guidance. The company’s AI innovations and expanding BNPL offerings are key growth engines.

Nine Entertainment reported a resilient FY25 with strategic transformation gains, digital subscription growth, and a major capital return following the sale of its Domain stake. Leadership changes and regulatory challenges frame its path forward.

Tivan Limited has initiated a comprehensive program of works at its recently acquired Molyhil Tungsten-Molybdenum Project, setting the stage for drilling and resource expansion in early 2026.

AVITA Medical reported an 18% revenue increase in Q3 2025 driven by new product launches and deeper market penetration, while continuing to face net losses and credit covenant challenges. The company also announced a CEO departure and interim leadership appointment.

The Calmer Co. International Limited announces a leadership change with James S. Tonkin appointed Chairman as the company accelerates its U.S. market growth in natural kava products.

AVITA Medical reported a 13% drop in Q3 commercial revenue to $17.1 million but improved its net loss and secured CE Mark approval for RECELL GO in Europe, signaling strategic shifts ahead.

Aurum Resources reports strong high-grade gold intercepts from its extensive drilling program at the Boundiali Gold Project in Côte d’Ivoire, boosting resource confidence ahead of major updates in early 2026.

Perpetual Resources has certified exceptionally high caesium grades up to 28.3% Cs2O at its Morro Grande prospect in Brazil’s Lithium Valley, reinforcing its potential as a major critical minerals source.

Tanami Gold NL has updated its Central Tanami Project Mineral Resource Estimate, boosting total gold resources to 2.8 million ounces. This increase reflects recent drilling, higher gold price assumptions, and improved metallurgical recoveries across multiple deposits.

Macquarie Group Limited reported a 3% increase in net profit to A$1.655 billion for the half year ended 30 September 2025, driven by robust performances in its asset management and capital segments. The Group’s diversified funding and strong capital position underpin its strategic growth and climate finance initiatives.

Macquarie Bank Limited reported a robust half-year profit of AUD 3.67 billion, up 61% from the prior period, driven by strategic asset sales and strong loan growth. The bank’s capital position remains solid amid ongoing investments in technology and risk management.

MedAdvisor Limited has appointed John Ciccio as its new CEO and Managing Director, marking a strategic leadership shift aimed at capitalising on recent technology advancements and US market growth.

Macquarie Group reported a solid half-year profit increase despite a sequential dip, boosted by strong asset management and capital markets performance. The group also extended its share buyback and declared a steady interim dividend.

Macquarie Group Limited reported a 3% increase in profit for the half year ended 30 September 2025, driven by strong performances in asset management and capital advisory, while declaring a 35% franked interim dividend of $2.80 per share.

Sun Silver Limited’s latest re-assay results confirm near-surface antimony mineralisation at its Maverick Springs Project, reinforcing its potential as a critical minerals hub alongside silver and gold. This comes as JPMorgan’s landmark US$75 million investment in U.S. antimony projects signals growing strategic focus on domestic mineral security.